SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001213900-21-029675
Filing Date
2021-05-27
Accepted
2021-05-27 17:28:01
Documents
3

Document Format Files

Seq Description Document Type Size
1 POST-EFFECTIVE AMENDMENT NO. 2 TO FORM F-1 ea141808-posam_nlspharma.htm POS AM 242480
2 CONSENT OF PRICEWATERHOUSECOOPERS AG. ea141808ex23-1_nlspharma.htm EX-23.1 2438
3 GRAPHIC image_001.jpg GRAPHIC 41119
  Complete submission text file 0001213900-21-029675.txt   302618
Mailing Address ALTER POSTPLATZ 2 STANS V8 CH-6370
Business Address ALTER POSTPLATZ 2 STANS V8 CH-6370 41-41-618-80-00
NLS Pharmaceutics Ltd. (Filer) CIK: 0001783036 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-236797 | Film No.: 21974349
SIC: 2834 Pharmaceutical Preparations